SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000948046-04-000113
Filing Date
2004-03-01
Accepted
2004-02-27 17:56:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 FILING SCHEDULE 13G/A transkaryoticamend5.txt SC 13G/A 13171
  Complete submission text file 0000948046-04-000113.txt   14966
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 04636854
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

IRS No.: 13294498 | State of Incorp.: I8